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Introduction: When pure ground-glass opacity (GGO) lesions are
detected in patients with otherwise operable non-small cell lung
cancer, it is controversial whether to resect them simultaneously
with the primary tumor or not.
Methods: We retrospectively reviewed radiologic features and
pathologic diagnoses of pure GGO lesions detected in otherwise
operable non-small cell lung cancer. Forty lesions were identified in
23 patients. Four of the eight lesions that were simultaneously
resected at surgery for the primary tumor turned out to be malignant.
During follow-up, four lesions increased in size and were resected
later. The remaining 28 lesions were considered nonmalignant
because the size did not change or decreased during follow-up. All
the lesions were divided into nonmalignant (n  32) and malignant
groups (n  8), and their clinical and radiologic features were
compared.
Results: There was no significant difference in clinical or pathologic
findings between the two groups. Median size of the lesions in the
nonmalignant group (5 mm) was significantly smaller than in the
malignant group (11 mm) (p  0.001). We tried to predict whether
a lesion is benign or malignant based on its size. With a cutoff value
of 8 mm, the sensitivity, specificity, positive predictive value,
negative predictive value, and accuracy were 88%, 81%, 53%, 96%
and 83%, respectively.
Conclusions: When a pure GGO is detected in otherwise operable
lung cancer, it should be resected to rule out the possibility of
malignancy if the size is greater than 8 mm. Nevertheless, if the size
is less than 8 mm, we suggest that it could be closely followed up
using imaging studies.
Key Words: Ground-glass opacity, Non-small cell lung cancer,
Radiologic features, Pathologic diagnoses.
(J Thorac Oncol. 2009;4: 1242–1246)
With recent advances in diagnostic imaging technologies,ground-glass opacity (GGO) lesions have been increas-
ingly detected on high-resolution computed tomography
(HRCT) scans.1–4 Because GGO lesions suggest early non-
small cell lung cancer (NSCLC), especially adenocarcinoma,
many studies have investigated their morphologic features
and histologic diagnoses.5–11 Nevertheless, when patients
diagnosed with NSCLC have GGO lesions in addition to the
primary tumor, little is known about their clinical, radiologic,
and pathologic characteristics.
Pathologic confirmation of the GGO lesions, in patients
with otherwise operable NSCLC, is required to determine
whether the lesions are malignant or benign. Nonetheless, if
a GGO lesion is located deep in the hilum or multiple GGO
lesions are scattered in different lobes, it is difficult to
perform a wedge resection for pathologic diagnosis in every
case.12 Nevertheless, it is controversial whether these GGO
lesions should be resected simultaneously with the primary
tumor or they could be followed up using computed tomog-
raphy (CT) scans after surgery for the primary tumor. A
better understanding of the relationship between the radio-
logic features and the pathologic diagnoses of GGO lesions
will be helpful in establishing the treatment plans in this
perplexing situation.
We retrospectively reviewed the clinical characteris-
tics, radiologic findings, and pathologic diagnoses of GGO
lesions detected in patients with otherwise operable NSCLC.
The objectives of this study are to determine the relation of
the radiologic findings to the pathologic diagnoses of GGO
lesions associated with NSCLC and to predict the pathologic
diagnoses of GGO lesions based on the radiologic features.
PATIENTS AND METHODS
Between September 1994 and December 2006, 2471
patients underwent pulmonary resection for NSCLC with
curative intent at our institution. Among these patients, 169
had single or multiple GGO lesions in addition to the primary
tumor on the preoperative CT scans. Patients who had local-
ized and pure GGO without any solid component were
included in this study. Patients who had GGO with a solid
component were excluded (n 47). Patients who had diffuse
GGO (n  42) or had no definite primary tumor (n  18)
were excluded. Patients were also excluded if GGO lesions
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were in the same lobe as the primary tumor (n 19), because
decision making in these patients was easier compared with
the cases in which the GGO lesions were located in lobes
different from the primary tumor. Patients who underwent
neoadjuvant therapy (n  12) or died immediately after
surgery (n  8) were also excluded. Accordingly, 23 patients
fulfilled these criteria, and they constituted the study popu-
lation. Their medical records were retrospectively reviewed
to evaluate the clinical characteristics, histopathologic results,
and long-term outcomes. This study was reviewed and ap-
proved by the Institutional Review Board of Samsung Med-
ical Center.
The clinical and pathologic staging was based on the
Tumor, Node, Metastasis (TNM) classification of malignant
lung tumors.13 Simultaneous resection of GGO lesions at
surgery for primary tumor was selectively performed. When
the size of the lesions was smaller than 10 mm or they were
located deep in the hilum, we tended to follow them up by
serial CT scans without surgical resection. Histologic diag-
noses were assessed according to the revised World Health
Organization histologic classification system.14 When the
histologic types of primary tumors were the same as those of
GGO lesions, differentiation between multiple primary can-
cers and lung-to-lung metastasis was based on the criteria
proposed by Martini and Melamed.15
Scanning and image reconstruction for single-detector
row helical CT were performed with a section thickness of 7
mm, a pitch of 1, and a reconstruction interval of 7 mm; for
four-, eight-, or 16-detector CT, beam width of 10 mm, a
beam of 1.375–1.5, and a reconstruction interval of 2.5–5.0
mm were set. The images were processed using a level of 20
Hounsfield unit (HU) and a width of 400 HU for mediastinal
windows and a level of700 HU and a width of 1500 HU for
lung windows. The preoperative CT scans were retrospec-
tively assessed by a radiologist unaware of the clinical findings
and pathologic diagnoses of the GGO lesions. The longest
diameters of the GGO lesions were measured. The shapes were
classified as round, oval, or polygonal. The marginal character-
istics were classified as smooth, lobulated, or spiculated. The
attenuation values of GGO lesions were also recorded on unen-
hanced thin-section CT scans. The typical HRCT images of
GGO lesions were shown in Figure 1.
GGO lesions were divided into malignant and nonma-
lignant groups based on the histopathologic diagnoses when
the lesions were surgically resected. For GGO lesions that
were followed up by serial CT scans without surgical resec-
tion, when they decreased in size or disappeared during
follow-up, they were considered to be nonmalignant. For
GGO lesions that remained unchanged in size during follow-
up, we considered them to be nonmalignant only when the
follow-up duration was longer than at least 1 year.
Descriptive statistics were used to describe the patient
characteristics and outcomes. The normally distributed con-
tinuous data was expressed as means  standard deviations.
Categorical data were expressed as counts and proportions.
The Student’s t test and the 2 or Fisher’s exact test tests were
used to compare continuous and categorical variables, respec-
tively. Significance was accepted at values of p  0.05.
RESULTS
Clinical Characteristics
The mean age was 60.2  10.3 (range, 38–78) years.
Eight patients were men and 15 were women. Nineteen
patients were nonsmokers. The histologic type of the primary
tumor was adenocarcinoma in 15 patients, bronchioloalveolar
carcinoma in four, squamous cell carcinoma in three, and
adenosquamous cell carcinoma in one. The TNM classifica-
tion was T1N0 in 10 patients, T2N0 in seven, T2N1 in two,
T2N2 in 3, and T3N2 in one. The clinical characteristics and
pathologic findings of the patients are shown in Table 1.
Radiologic Features of GGO
The retrospective review of the CT scans showed that a
total of 40 GGO lesions were identified in the study popula-
tion. Thirteen patients had a single GGO lesion, whereas 10
had multiple GGO lesions. The median number of GGO
lesions was 2 (range, 1–5). The GGO lesions were located
with regard to the primary tumor ipsilaterally in six patients,
contralaterally in 13 and bilaterally in four. Thirteen patients
had integrated positron emission tomography-CT scanning,
which showed no uptake (n10) or faint uptake (n 3) in all
the cases.
Management of GGO Lesions
Eight GGO lesions were resected simultaneously at
surgery for primary tumor, whereas the remaining 32 GGO
lesions were followed up by CT scans. The pathologic diag-
noses of the eight lesions simultaneously resected were bron-
chioloalveolar carcinoma in three cases, adenocarcinoma in
one, atypical adenomatous hyperplasia in one, and benign
FIGURE 1. Typical high-resolution computed tomography
(HRCT) images of ground-glass opacity (GGO) lesions. A,
The 10-mm round GGO nodule with slightly lobulated mar-
gin. B, The 8-mm oval GGO nodule with lobulated margin.
C, The 11-mm polygonal GGO nodule with smooth margin.
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lesion in one. During follow-up, four GGO lesions increased
in size, and they were resected later. The pathologic diag-
noses of these four lesions were adenocarcinoma in three and
bronchioloalveolar carcinoma in one. On the other hand,
among the remaining 28 GGO lesions, six lesions disap-
peared, two decreased in size, and 20 showed no change in
size with a median follow-up duration of 23.8 months. Con-
sequently, these 28 GGO lesions were considered nonmalig-
nant because their clinical features were indolent. We accept
that stability over the observed time period does not exclude
the possibility of a very indolent malignancy but from a
management standpoint treating such lesions as if they were
benign appears justified. All the GGO lesions were divided
into nonmalignant (n  32) and malignant groups (n  8),
and the clinical and radiologic features were compared.
Comparative Analysis of GGO Lesions
No significant differences were observed between the
nonmalignant and the malignant groups with regard to age,
gender, smoking status, histologic diagnoses of the primary
tumor, and pathologic stages of the primary tumor. There was
no significant difference in the follow-up duration between
the nonmalignant (median, 17 months; range, 7–56 months)
and the malignant groups (median, 25 months; range, 9–71
months) (p  0.73). The radiologic features of the GGO
lesions were compared between the two groups (Table 2). The
mean size of the lesions in the nonmalignant group (median, 5
mm; range, 3–24 mm) was significantly smaller than that of the
malignant group (median, 11 mm; range, 6–15 mm) (p 
0.001). The comparative distribution of the GGO size between
the two groups is illustrated in Figure 2. Except for the size, there
were no significant differences identified between the two
groups with regard to other radiologic features such as the shape,
margin, and attenuation values.
Prediction of Pathologic Diagnosis of GGO
Prediction of the GGO lesion as nonmalignant or ma-
lignant was attempted based on its size on the CT images. A
receiver operating characteristic (ROC) curve analysis was
performed to determine the appropriate cutoff value and to
evaluate the accuracy of the prediction based on the radio-
logic features, especially based on the size of the GGO lesion.
The ROC curve analysis showed that the most appropriate
cutoff value was 7.5 mm, and the area under ROC curve was
0.89 (Figure 3). With a cutoff value of 8 mm, the sensitivity,
specificity, positive predictive value, negative predictive
TABLE 1. The Clinical Characteristics and Pathologic
Findings of Patients
Characteristics
No. of patients (n) 23
Age at operation (years, mean  SD) 60.2  10.3 (38–78)
Male: female 8:15
History of smoking (n)
Nonsmoker 19
Current smoker 3
Exsmoker 1
Radiologic features of primary tumor (n)
Pure GGO 4
Mixed GGO 8
Solid nodule 11
Pathologic type of primary tumor (n)
Adenocarcinoma 15
BAC 4
SCC 3
Adenosquamous 1
Pathologic TNM stage of primary tumor (n)
T1N0 10
T2N0 7
T2N1 2
T2N2 3
T3N2 1
SD, standard deviation; GGO, ground-glass opacity; BAC, bronchioloalveolar
carcinoma; SCC, squamous cell carcinoma; TNM, tumor, node, metastasis.
TABLE 2. The Comparison of the Radiologic Features of the Ground-Glass Opacity Lesion Between
the Benign and the Malignant Groups
Characteristics Nonmalignant Malignant p Chance of Malignancy (%)
No. of GGO (n) 32 8
Size of GGO (mm, median, range) 5 (3–24) 11 (6–15) 0.001
5 mm 12 — 0
5–10 mm 17 2 11
10 mm 3 6 67
Shape of GGO 0.64
Round 20 4 17
Oval 10 4 29
Polygonal 2 — 0
Margin of GGO 0.054
Smooth 25 3 11
Lobulated 6 5 45
Spiculated 1 — 0
Attenuation value (HU, mean  SD) 605.3  118.3 530.0  70.9 0.094
GGO, ground-glass opacity; SD, standard deviation; HU, Hounsfield unit.
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value, and accuracy were 88%, 81%, 53%, 96%, and 83%,
respectively.
DISCUSSION
Recent advances in diagnostic imaging technologies
have increased the detection of GGO lesions on HRCT
scans.1–4 The enhanced resolution of imaging studies makes
it possible to detect early lung cancer presenting as a solitary
GGO lesion. Many authors have reported the morphologic
features and histologic diagnoses of GGO lesions.5–11 Nakata
et al.5 retrospectively evaluated the pathologic and radiologic
features of focal GGO lesions less than 2 cm in size, and they
showed that GGO lesions greater than 1 cm or GGO lesions
with a solid component suggested the presence of a malig-
nancy. Similarly, GGO lesions are also being frequently
detected in addition to the primary tumor during the staging
workup in patients with NSCLC. Nevertheless, compared
with the previous studies, little has been reported on GGO
lesions associated with NSCLC. This study have dealt with
the GGO lesions additionally detected in patients with
NSCLC and investigated the relationship between the radio-
logic findings and pathologic diagnoses.
When GGO lesions are found in patients with otherwise
operable NSCLC, decision making on these lesions is difficult.
Considering that these lesions are additionally detected in pa-
tients with malignancy, it is important to determine what the
lesion really is. Nevertheless, it is controversial whether they
should be simultaneously resected at surgery for primary tumor
or they could be followed up after surgery for primary tumor.
Among 40 GGO lesions, eight pathologically proved to be
malignant, and thus overall malignancy rate was 20% (8 of 40
GGO lesions). Among the eight malignant GGO lesions,
none of them were lung-to-lung metastasis. Among the 32
GGO lesions that were closely observed after surgery for
primary tumor, four lesions increased in size during fol-
low-up and were resected later, which turned out to be
malignant. For the remaining 28 lesions, most of them did not
show any change in size, decreased in size, or disappeared
during the follow-up. These findings suggest that GGO le-
sions associated with NSCLC do not necessarily mean ma-
lignant lesions. If we had decided not to perform a surgical
resection for these patients due to the associated “benign”
GGO lesions, they would have lost the opportunity for a
curative resection based on groundless concerns.
Some authors demonstrated that preoperative diagnosis
of lung cancer detected by screening with HRCT could be
reliably made by fine needle aspiration.16 Nevertheless, for
GGO dominant small lesions, it is not feasible to confirm the
pathology of GGO lesions by CT-guided needle aspiration
biopsy, because the diagnostic yield tends to be low.17 Even
if we decide to resect GGO lesions, it is also difficult to
perform a pathologic confirmation when the GGO lesion is
located deep in the hilum or when multiple GGO lesions are
scattered in different lobes.12 For these reasons, prediction of
the pathologic diagnosis of GGO lesions based on radiologic
findings would offer important information. In this study, we
compared the radiologic findings of GGO lesions between the
nonmalignant and the malignant groups. Thereby, we tried to
predict the pathologic nature of the GGO lesions using
radiologic findings on thin-section CT scans.
Our results showed that there were no significant dif-
ferences between the two groups with respect to the radio-
logic features such as the shape, margin, and attenuation
values. Nevertheless, the median size of the GGO lesions in
the nonmalignant group was significantly smaller than that of
the malignant group. These findings suggest that when GGO
lesions, in patients with NSCLC, are considerably small, they
are more likely to be benign. Recently, Hiramatsu et al.18
showed that initial GGO size and a history of lung cancer
were independent factors that were significantly associated
with GGO growth during follow-up. They showed that the
growth incidence at 5 years was 66% when the GGO lesions
were larger than 10 mm. In our series, the chance of malig-
nancy was 67% for lesions larger than 10 mm. To determine
the appropriate cutoff value for the size that most accurately
predicts the pathologic nature of the GGO, we performed a
ROC curve analysis and a cutoff value of 7.5 mm was
obtained. With a cutoff value of 8 mm, the sensitivity,
specificity, positive predictive value, negative predictive
value, and accuracy were 88%, 81%, 53%, 96%, and 83%,
FIGURE 2. The comparative distribution of the ground-
glass opacity size between the nonmalignant and the malig-
nant groups.
FIGURE 3. A receiver operating characteristic curve analysis.
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respectively. For GGO lesions larger than 8 mm, the chance
of malignancy was 53%, whereas for GGO lesions smaller
than 8 mm, the chance of benignancy was 96%. This means
that when GGO lesions are smaller than 8 mm, the chance of
malignancy seems to be very low, and we can follow them up
without pathologic confirmation.
There are several limitations of our study. Because our
data were retrospectively collected in a small series, our
attempt to predict the pathologic diagnosis of GGO lesions
based on the radiologic features cannot be automatically
applied to other series. It should also be stated that 28 GGO
lesions were considered to be nonmalignant without any
pathologic confirmation based only on their clinically indo-
lent nature. Possibly, a low-grade malignancy such as non-
mucinous bronchioloalveolar carcinoma might have been
present in these lesions. In fact, there have been several
reports on the malignancy potential of persistent GGO lesions
that show no change in their size during follow-up.6,19 The
observation that these lesions have an indolent natural course
does not necessarily mean that they are histologically benign.
Additionally, in cases with multiple GGO lesions where only
one lesion was pathologically confirmed, there is no guaran-
tee that the pathologically confirmed lesion would represent
the remaining lesions. Despite the similar morphology, it
cannot be definitely concluded that they have the same
pathologic diagnoses. Therefore, for more conclusive and
persuasive results, prospective data acquisition from a large
cohort is needed with pathologic confirmation of the diagno-
sis on all GGO lesions.
In summary, we retrospectively reviewed the radiologic
findings and pathologic diagnosis of GGO lesions detected in
patients with otherwise operable NSCLC. We compared the
morphology on CT scans between the nonmalignant and
malignant lesions. Median size of the GGOs in the nonma-
lignant group was significantly smaller than that of the lesions
in the malignant group. Therefore, when a pure GGO lesion
is detected in patients with otherwise operable NSCLC, our
results suggest that it should be resected to rule out the
possibility of malignancy if the size is greater than 8 mm.
Nevertheless, if the size is less than 8 mm, we suggest that it
could be closely followed up using imaging studies.
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